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(PRA and PRC), renal and cardiac hypertrophy in NALP3 and ASC deﬁcient mice
on which the two-kidney, one clip (2K1C) and the deoxycorticosterone-acetate
(DOCA)/salt models were applied. MBP, PRA, PRC, and HW/BW were
signiﬁcantly increased at week 12 in WT-2K1C mice compared to the sham.
Neither NLAP3-KO nor ASC-KO 2K1C treated mice developed hypertension and
had lower circulating levels of PRA and PRC and serum amyloid A (SAA) and IL6
compared to the control. RNA levels of SAA, NLRP3, IL1b and IL1a were
increased in the ischemic kidney in C57BL/6J mice. Administration of anti-IL1b
antibody to the WT mice attenuated the increases of blood pressure and renin
in 2K1C mice. With chronic administration of DOCA/salt, MBPs in both NLRP3-
KO andWT mice were comparable and not signiﬁcantly increased compared to
tap water group. PRA and PRC in both NALP3-KO and WT mice were
signiﬁcantly suppressed by DOCA/salt. HW/BW and KW/BW in both DOCA/salt
treated NALP3-KO and WT mice were signiﬁcantly increased. DOCA/salt
induced hypokalemia was comparable between Nlrp3 KO and WT groups.
However, the heart and kidney index in DOCA/salt NLRP3-KO mice was
signiﬁcantly lower than that in DOCA/salt WT mice. Our data show that NLRP3
mediated IL1b is linked to development of renovascular hypertension and
suggest that a novel target for the treatment of hypertension. The results also
implicate that NLRP3 contributes to the development of cardiac and renal
hypertrophy independently of blood pressure in the DOCA/salt model.
http://dx.doi.org/10.1016/j.krcp.2012.04.586
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THE IMPACT OF BODY WEIGHT MANAGEMENT IN CHRONIC KIDNEY
DISEASE PATIENTS WITH OBESITY
Ya-Ling Wang, Kuo-Hsiung Shu, Mei-Fang Yang, Wen-Ching Yang, Ming-
Ju Wu, Cheng-Hsu Chen
Taichung Veterans General Hospital, Taichung, Taiwan
Chronic kidney disease (CKD) and obesity are important public health
concerns. We examined the inﬂuence of dietary management and physical
exercises on renal function, lipid proﬁles and exercise tolerance of a group of
CKD patients. We enrolled 45 obese patients with CKD from stage 1 to 3b with
tailored by regular dietitian consultation, recommendations of adequate daily
protein and caloric intake, and physical exercises for body weight (BW)
reduction. The target was BW reduction Z 3%. Thirty eight obese CKD patients
completed the study and 24 patients reached the target. Patients who reached
the target was signiﬁcant larger in total body fat decrement than those who
failed (3.0% vs 0.5%, p ¼ 0.003). In addition, total muscle mass, especially on
trunk and lower limbs (1.2% vs 0%, P ¼ 0.026) was signiﬁcant decreased in
patients who reached the target compared to those who failed. The laboratory
data disclosed the signiﬁcant reduction of Chol (0.7% vs. -19.3%; P ¼ 0.007),
LDL-C ( 3.7% vs. -37.6%; P o 0.001), and UA (0% vs. -0.8%; P ¼ 0.025) between
the two groups. The cardiorespiratory endurance to complete 800 meters run
(375.1 7 64.7 sec vs. 327.1 7 84.0 sec; P ¼ 0.001), abdominal muscle strength
and endurance by times of sit-ups (13.6 7 9.1 number/min vs. 19.9 7 9.2; P ¼
0.005), and ﬂexibility of the lower back by sit and reach (18.8 7 10.8 cm vs.
27.8 7 10.9 cm; Po 0.001) of the patients who reached the target were
improved signiﬁcantly after 2-months of physical exercise training and
education.We conclude that combination of dietary management and exercises
are effective in improving health-related physical ﬁtness, blood pressure
control, dyslipidemia and renal function in overweight or obese CKD patients.
Supportive individualized programs for lifestyle change could exert beneﬁcial
effects. A longitudinal study with larger sample size is warranted to elucidate
the efﬁcacy of combination of dietary management and exercises.
http://dx.doi.org/10.1016/j.krcp.2012.04.587
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CXCL16 REGULATES ANGIOTENSIN II-INDUCED INFLAMMATION
AND PROTEINURIA
Yanlin Wang, Yunfeng Xia
Baylor College of Medicine, Houston, Texas.
Hypertension is a major cause of chronic kidney disease. Recent studies have
shown that inﬂammation plays a critical role in the pathogenesis and
progression of hypertensive kidney disease. However, the signaling
mechanisms underlying the induction of inﬂammation are poorly understood.
We have found that CXCL16, a recently discovered chemokine, is induced in the
kidney in a murine model of angiotensin II (Ang II)-induced hypertension.
Therefore, we examined whether CXCL16 regulates inﬂammatory cell
inﬁltration and renal injury using CXCL16 knockout (CXCL16-KO) mice. Wild-
type (WT) and CXCL16-KO mice were treated with Ang II via subcutaneous
osmotic minipumps at 1500 ng/kg/min for up to 4 weeks. To accelerate renal
injury, all mice were subjected to unilateral nephrectomy and received 1% NaCl
in drinking water. WT and CXCL16-KO mice had virtually identical blood
pressure at baseline. Ang II treatment led to an increase in blood pressure that is
similar between WT and CXCL16-KO mice. Immunohistochemical analysis
showed that targeted disruption of CXCL16 inhibits inﬁltration of F4/80þ
macrophages and CD3þ T cells in the kidney of Ang II treated mice compared
with WT mice. Real time RT-PCR demonstrated that targeted disruption of
CXCL16 reduced gene expression of inﬂammatory cytokines (IL-1b and TNF-a)
in the kidney of Ang II treated mice. Histological analysis revealed that CXCL16
deﬁciency inhibited Ang II-induced renal injury. Furthermore, targeted deletion
of CXCL16 reduced Ang II-induced proteinuria and podocyte loss. In Summary,
our results indicate that CXCL16 plays a pivotal role in the development of renal
injury and proteinuria through regulation of macrophage and T cell inﬁltration.
http://dx.doi.org/10.1016/j.krcp.2012.04.588
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STUDY MECHANISMS OF LOW PROTEIN DIET SUPPLEMENTED WITH
KETOANLOGS ON REDUCING PROTEINURIA AND MINTINING
NUTRITIONAL STATUS IN TYPE2 DIBETIC NEPHROPTHY
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Shanghai 200080, China. Sponsored by Int Kidney Disease Nutrition Foundation
Diabetic nephropathy is one of the most important causes of end stage renal
disease (ESRD) in the world. Recently in a multicenter, randomized clinical trial
performed in China, it was found that compound a-keto acid tablet in
combination with low protein diet(LPDþKA) reduced proteinuria and delayed
the progression to ESRD in Type 2 diabetic nephropthy(T2DN). However, the
mechanisms underlined these effects were not been elucidated. This study is a
part of the continuation of the study to explore the effects of LPDþKA on
podocyte as well as on local RAS in the kidney. A total of 60 patients with T2DN
and CKD stages 3–4 are included in this study. All patients are treated with a
LPD containing 0.6g protein/kg BW per day and 120–125 kJ/kg BW per day. The
diet is randomly supplemented with keto-amino acids (Ketosterils, Fresenius
Kabi) at a dosage of 100 mg/kg BW per day. The other 30 patients receive
placebo. After six months of follow-up, protein intake differed only by 0.07 g/
kg/day between the two groups. The mean declines in GFR were 4.2 mL/min/
year (95%CI;2.9 to 5.5) in LPD group and 3.7 (95%CI; 2.7 to 4.7) in LPDþKA
group. Compared with LPD, paitients in LPDþKA group had reduced proteinuria
(2.1670.4 vs 3.5670.6 g/day; p/0.05). However, serum albumin and
prealbumin levels did not change. Through further research we found that, after
a median follow-up for six months, the urinary angiotensinogen:creatinine ratio
in LPD patients was higher than in LPDþKA subjects (10.1 73.2 mg/g vs 5.8 7
1.2 mg/g; p/0.05);The urinary mRNA levels of the target genes nephrin, podocin
and synaptopodin of podocyte were higher in the LPD group compared with
LPDþKA(p/0.05) in urinary sediment, and the expression of nephrin, podocin
and synaptopodin mRNA positively correlated with serum creatinine (r¼0.326,
p ¼ 0.04; r ¼ 0.426, p ¼ 0.03; r ¼ 0.343, p ¼ 0.001, respectively). In
conclusion, compound a-keto acid tablet in combination with low protein diet
(LPDþKA) is associated with amelioration of proteinuria, better reduction in the
loss of kidney function compared with LPD alone meanwhile nutrition status
remained well. The mechanism under these effects may be explained by the
role of LPDþKA diet in reducing urine podocyte loss and lowering the
angiotensinogen level in the urine.
http://dx.doi.org/10.1016/j.krcp.2012.04.589
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SUPPLEMENTED WITH a-KETOACIDS THERAPY ON NUTRITION STATUS
AND RESIDUAL RENAL FUNCTION IN CONTINUOUS AMBULATORY
PERITONEAL DIALYSIS(CAPD) PATIENTS
Juan Huang, Weijie Yuan, Yi Zhou, Xuan Wang, Ting Wang
Department of Nephrology, Shanghai Jiaotong UniversityAfﬁliated First People’s
Hospital, Shanghai 200080, China
It is critical to preserve residual renal function (RRF) in CAPD, as RRF is
associated with lower morbidity and mortality. low- protein diet supplemented
with a-keto acids was reported to have an important roles in delaying in
follow-up period progression of renal failure and relieving malnutritional status
in non-dialysis patients with chronic renal failure. We evaluate the effects on
the nutritional status and RRF of a low-protein diet supplemented with a-keto
acids on CAPD patients prospectively. Seventy eight CAPD patients who were
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